ArticleInternational journal of molecular sciences2021

Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors Reduce Platelet Activation Modulating ox-LDL Pathways.

Vittoria Cammisotto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.